Amylyx Pharmaceuticals (AMLX) Property, Plant & Equipment (Net) (2021 - 2026)

Amylyx Pharmaceuticals (AMLX) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Haleon	89.15 Bn	87.28 Bn	-	37.35 Bn
2	Teva Pharmaceutical Industries	35.89 Bn	32.15 Bn	1.97 Bn	4.00 Bn
3	Zoetis	32.49 Bn	30.55 Bn	1.62 Bn	3.72 Bn
4	Takeda Pharmaceutical	27.56 Bn	23.50 Bn	4.39 Bn	13.52 Bn
5	United Therapeutics	23.20 Bn	21.05 Bn	648.10 Mn	1.84 Bn
6	RedHill Biopharma	21.76 Bn	21.76 Bn	-	49,000.00
7	Viatris	20.28 Bn	18.48 Bn	1.16 Bn	2.53 Bn
8	Neurocrine Biosciences	17.74 Bn	16.43 Bn	800.70 Mn	90.90 Mn
9	Elanco Animal Health	12.58 Bn	12.15 Bn	785.00 Mn	1.40 Bn
10	Amylyx Pharmaceuticals	2.13 Bn	2.13 Bn	-	212,000.00

Download Data